Egyptian Drug Authority Chairman Ali El Ghamrawy has held a meeting with a delegation from Reme-D, the Egyptian developer of PCR kits and devices, led by founder and CEO Salma Tammam, to discuss strategic cooperation in the health sector. The meeting focused on strengthening collaboration to support and develop Egypt's healthcare system in line with the state's vision of improving service quality and ensuring access to the latest medical technologies. El Ghamrawy said the talks reflect the authority's commitment to fostering innovation and adopting advanced medical technologies. He noted that partnership with Reme-D represents a successful model of cooperation between the public sector and leading national firms, adding that the authority is prioritising streamlined regulations and an investment-friendly environment to accelerate the entry of advanced medical devices into the Egyptian market and enhance healthcare quality. Attribution: Amwal Al Ghad English Subediting: M. S. Salama